Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non–small-cell lung cancer: a propensity-matched retrospective study

Fig. 2

Kaplan–Meier curves for PFS (a) and OS (b) in patients treated with TKIs + SBRT or TKIs alone; Kaplan-Meier curves of PFS for 45 patients in the TKIs + SBRT group (c) and 16 patients with poly-metastatic disease in the TKIs + SBRT group (d). PFS progression-free survival, OS overall survival, TKIs tyrosine kinase inhibitors, SBRT stereotactic body radiation therapy, CI confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us